献血者血小板功能差异对输血结局的影响:一项半随机对照试验
本研究探讨献血者血小板体外反应性高低对患者预防性血小板输注后血小板计数增量的影响。51例接受低反应者血小板、49例接受高反应者血小板,输注后10-90分钟血小板计数增量无显著差异(均值21.0×10^9/L vs 23.3×10^9/L,P=0.18)。结果支持当前不根据血小板功能选择献血者的政策。
要点
- 高反应者献血者血小板输注后10-90分钟血小板计数增量均值21.0×10^9/L。
- 低反应者献血者血小板输注后增量均值23.3×10^9/L,两组差异无统计学显著(P=0.18)。
- 结果支持预防性血小板输注不按献血者血小板功能筛选的现行政策。
核心结论
- 献血者血小板体外高反应性并未导致输注后血小板计数增量更低,结果支持不根据血小板功能选择献血者的现行政策。
研究设计与样本
- 平行组、半随机、双盲试验,在英国单中心开展。
- 纳入16岁及以上、因骨髓衰竭导致血小板减少、需预防性血小板输注的患者。
- 高反应者组49例(其中47例随机、53例非随机),低反应者组51例。
- 主要终点为输注后10至90分钟血小板计数增量,按意向性分析。
主要发现
- 高反应者组输注后10-90分钟血小板计数增量均值21.0×10^9/L(95%CI 4.9-37.2)。
- 低反应者组增量均值23.3×10^9/L(95%CI 7.8-38.9)。
- 两组均值差2.3(95%CI -1.1至5.7;P=0.18),无显著差异。
临床怎么用
- 作者结论支持现行不根据献血者血小板功能选择血小板用于预防性输注的政策。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The effect of variation in platelet function in platelet donors on patient outcome following platelet transfusion is unknown. This trial assessed the hypothesis that platelets collected from donors with highly responsive platelets to agonists in vitro assessed by flow cytometry (high-responder donors) are cleared more quickly from the circulation than those from low-responder donors, resulting in lower platelet count increments following transfusion. This parallel group, semirandomized double-blinded trial was conducted in a single center in the United Kingdom. Eligible patients were those 16 or older with thrombocytopenia secondary to bone marrow failure, requiring prophylactic platelet transfusion. Patients were randomly assigned to receive a platelet donation from a high- or low-responder donor when both were available, or when only 1 type of platelet was available, patients received that. Participants, investigators, and those assessing outcomes were masked to group assignment. The primary end point was the platelet count increment 10 to 90 minutes following transfusion. Analysis was by intention to treat. Fifty-one patients were assigned to receive platelets from low-responder donors, and 49 from high-responder donors (47 of which were randomized and 53 nonrandomized). There was no significant difference in platelet count increment 10 to 90 minutes following transfusion in patients receiving platelets from high-responder (mean, 21.0 × 109/L; 95% confidence interval [CI], 4.9-37.2) or low-responder (mean, 23.3 × 109/L; 95% CI, 7.8-38.9) donors (mean difference, 2.3; 95% CI, -1.1 to 5.7; P = .18). These results support the current policy of not selecting platelet donors on the basis of platelet function for prophylactic platelet transfusion.
引用
- Kelly AM, Garner SF, Foukaneli T, et al. The effect of variation in donor platelet function on transfusion outcome: a semirandomized controlled trial. Blood. 2017. PMID: 28487294. doi:10.1182/blood-2017-01-759258
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。